ArticleMolecular biomedicine2022

Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma.

Kendra R Vann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.